FDA / 2025

Forzinity prescribing information

Forzinity prescribing information — U.S. FDA (2025), cited in PeptideAgent's SS-31 / Elamipretide evidence record.

Open original source

SOURCE METADATA

What this record represents.

Publisher
U.S. FDA
Evidence type
FDA
Publication year
2025
Source ID
fda-forzinity-label

WHERE THIS IS CITED

Connected evidence records.

SS-31 / ElamipretideSynthetic peptide · Longevity